Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients

NCT03262584 is registered in ClinicalTrials.gov with Karius, Inc. as lead sponsor.

NCT NCT03262584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03262584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Lead sponsor
Karius, Inc.
Phase
Observational
Overall status
Completed
Start date
May 17, 2017
Completion date
September 28, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fever and neutropenia, immunocompromised, invasive fungal disease, invasive fungal infections